FACTOR-VIII COAGULANT ANTIGEN IN FACTOR-IX COMPLEX CONCENTRATES

[1] ALLAIN JP, 1975, LANCET, V2, P1203

[2] STUDIES ON NATURE OF CIRCULATING ANTICOAGULANT DIRECTED AGAINST ANTIHEMOPHILIC FACTOR - WITH NOTES ON AN ASSAY FOR ANTIHEMOPHILIC FACTOR [J]. BLOOD, 1962, 20 (02) : 137 - +

[3] HOYER LW, 1972, J LAB CLIN MED, V80, P822

[4] KASPER CK, 1976, NEW ENGL J MED, V295, P505

[5] KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869

[6] LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209

[7] MANNUCCI PM, 1976, LANCET, V1, P41

[8] PALASCAK JE, 1977, NEW ENGL J MED, V297, P1403

[9] FAILURE OF FACTOR-VIII INHIBITOR BYPASSING ACTIVITY (FEIBA) TO SECURE HEMOSTASIS IN HEMOPHILIC PATIENTS WITH ANTIBODIES [J]. JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (11) : 1102 - 1105

[10] STENBJERG S, 1978, ACTA MED SCAND, V203, P471

[1] ALLAIN JP, 1975, LANCET, V2, P1203

[2] STUDIES ON NATURE OF CIRCULATING ANTICOAGULANT DIRECTED AGAINST ANTIHEMOPHILIC FACTOR - WITH NOTES ON AN ASSAY FOR ANTIHEMOPHILIC FACTOR [J]. BLOOD, 1962, 20 (02) : 137 - +

[3] HOYER LW, 1972, J LAB CLIN MED, V80, P822

[4] KASPER CK, 1976, NEW ENGL J MED, V295, P505

[5] KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P869

[6] LAZARCHICK J, 1978, J CLIN INVEST, V62, P1048, DOI 10.1172/JCI109209

[7] MANNUCCI PM, 1976, LANCET, V1, P41

[8] PALASCAK JE, 1977, NEW ENGL J MED, V297, P1403

[9] FAILURE OF FACTOR-VIII INHIBITOR BYPASSING ACTIVITY (FEIBA) TO SECURE HEMOSTASIS IN HEMOPHILIC PATIENTS WITH ANTIBODIES [J]. JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (11) : 1102 - 1105

[10] STENBJERG S, 1978, ACTA MED SCAND, V203, P471